GAVI Alliance Brings Pneumococcal Vaccine To Nicaragua
In this post in PBS NewsHour's blog "The Rundown," senior correspondent Ray Suarez reports on his time in Nicaragua with the NewsHour's global health unit for the national rollout of a pneumococcal pneumonia immunization campaign. The vaccine cost $100 per dose when it came to market in the last several years, Suarez notes, writing, "At that price, Nicaragua certainly couldn't pay to vaccinate all its children. The GAVI Alliance, formed as the Global Alliance for Vaccines and Immunization, worked to find a way to close that yawning gap between great danger to children and a life-saving medicine, between deep poverty in Nicaragua and Pfizer's high costs."
"The organization pools private and government donor dollars, and wins long-term commitments from recipient countries to acquire and deliver the vaccine," he continues, adding, "By doing this, GAVI gives business a predictable outcome for sales of a vaccine, something it might not otherwise have. Recipient governments, like Nicaragua, get massive discounts in return for their long-term assurances of a market. In the case of pneumococcal pneumonia vaccine, the price moved from roughly $100 to $3.75 cents" (10/26).This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.